...
首页> 外文期刊>Arteriosclerosis, thrombosis, and vascular biology >Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype.
【24h】

Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype.

机译:家族性高胆固醇血症在导致受体缺陷或受体阴性表型的LDL受体基因突变簇中的临床表达。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Seventy-one mutations of the low density lipoprotein (LDL) receptor gene were identified in 282 unrelated Italian familial hypercholesterolemia (FH) heterozygotes. By extending genotype analysis to families of the index cases, we identified 12 mutation clusters and localized them in specific areas of Italy. To evaluate the impact of these mutations on the clinical expression of FH, the clusters were separated into 2 groups: receptor-defective and receptor-negative, according to the LDL receptor defect caused by each mutation. These 2 groups were comparable in terms of the patients' age, sex distribution, body mass index, arterial hypertension, and smoking status. In receptor-negative subjects, LDL cholesterol was higher (+18%) and high density lipoprotein cholesterol lower (-5%) than the values found in receptor-defective subjects. The prevalence of tendon xanthomas and coronary artery disease (CAD) was 2-fold higher in receptor-negative subjects. In patients >30 years of age in both groups, the presence of CAD was related to age, arterial hypertension, previous smoking, and LDL cholesterol level. Independent contributors to CAD in the receptor-defective subjects were male sex, arterial hypertension, and LDL cholesterol level; in the receptor-negative subjects, the first 2 variables were strong predictors of CAD, whereas the LDL cholesterol level had a lower impact than in receptor-defective subjects. Overall, in receptor-negative subjects, the risk of CAD was 2.6-fold that of receptor-defective subjects. Wide interindividual variability in LDL cholesterol levels was found in each cluster. Apolipoprotein E genotype analysis showed a lowering effect of the epsilon2 allele and a raising effect of the epsilon4 allele on the LDL cholesterol level in both groups; however, the apolipoprotein E genotype accounted for only 4% of the variation in LDL cholesterol. Haplotype analysis showed that all families of the major clusters shared the same intragenic haplotype cosegregating with the mutation, thus suggesting the presence of common ancestors.
机译:在282个无关的意大利家族性高胆固醇血症(FH)杂合子中鉴定出低密度脂蛋白(LDL)受体基因的71个突变。通过将基因型分析扩展到索引病例的家庭,我们确定了12个突变簇,并将它们定位在意大利的特定地区。为了评估这些突变对FH临床表达的影响,根据每个突变引起的LDL受体缺陷,将簇分为两组:受体缺陷和受体阴性。这两组患者的年龄,性别分布,体重指数,动脉高血压和吸烟状况具有可比性。在受体阴性受试者中,与在受体缺陷受试者中发现的值相比,LDL胆固醇更高(+ 18%),高密度脂蛋白胆固醇更低(-5%)。在受体阴性受试者中,肌腱黄瘤和冠状动脉疾病(CAD)的患病率高2倍。两组年龄均大于30岁的患者中,CAD的存在与年龄,动脉高血压,既往吸烟和LDL胆固醇水平有关。受体缺陷受试者中CAD的独立贡献者是男性,动脉高血压和LDL胆固醇水平。在受体阴性受试者中,前两个变量是CAD的强力预测指标,而LDL胆固醇水平的影响要小于受体缺陷受试者。总体而言,在受体阴性受试者中,CAD的风险是受体缺陷受试者的2.6倍。在每个簇中发现LDL胆固醇水平的个体差异很大。载脂蛋白E基因型分析显示,epsilon2等位基因的降低作用和epsilon4等位基因对两组低密度脂蛋白胆固醇水平的升高作用。然而,载脂蛋白E基因型仅占LDL胆固醇变异的4%。单倍型分析表明,主要簇的所有家族都共享与突变共同分离的同一基因内单倍型,从而表明存在共同祖先。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号